Margaritescu et al. showed active angiogenesis in AcCCs, supported by elevated CD105-MVD scores and the IHC reactivity of tumor cells and ECs for VEGF and its receptors (VEGFR1 and VEGFR2). This evidence concerns the gene KDR and neoplasm.